Peptide-Based Subunit Nanovaccines

被引：101

作者：

Skwarczynski, Mariusz ^{[1
]}

Toth, Istvan ^{[1
]}

机构：

[1] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia

来源：

CURRENT DRUG DELIVERY | 2011年 / 8卷 / 03期

关键词：

Subunit vaccine; peptide epitope; nanotechnology; nanoparticles; infectious diseases; DRUG-DELIVERY SYSTEMS; FUNCTIONALIZED CARBON NANOTUBES; CROSS-LINKED NANOPARTICLES; GROUP-A STREPTOCOCCI; DENDRITIC CELLS; VACCINE DELIVERY; POLY(GAMMA-GLUTAMIC ACID); IMMUNE-RESPONSES; BIODEGRADABLE NANOPARTICLES; BIOMEDICAL APPLICATIONS;

D O I：

10.2174/156720111795256192

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Classical vaccines incorporating live or attenuated microorganisms possess several disadvantages and cannot be applied against cancer and some pathogens. Modern vaccines utilizing immunogenic subunits derived from a particular pathogen are able to overcome these obstacles but need a specific delivery system for their efficacy. Nanotechnology has opened a new window into these delivery methodologies. A nano-sized formulation of subunit vaccines has been proven to be very effective in inducing cellular and humoral immune responses. Here, we review a number of peptide vaccine delivery strategies based on nanoparticles composed of polymers, peptides, lipids, and inorganic materials.

引用

页码：282 / 289

页数：8

共 50 条

[21] Antitumor Peptide-Based Vaccine in the Limelight
Kumai, Takumi
Yamaki, Hidekiyo
Kono, Michihisa
Hayashi, Ryusuke
Wakisaka, Risa
Komatsuda, Hiroki
VACCINES, 2022, 10 (01)
[22] Adjuvants for peptide-based cancer vaccines
Khong, Hiep
Overwijk, Willem W.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
[23] Peptide-based materials for cancer immunotherapy
Zhang, Lu
Huang, Yanyu
Lindstrom, Aaron Raymond
Lin, Tzu-Yin
Lam, Kit S.
Li, Yuanpei
THERANOSTICS, 2019, 9 (25): : 7807 - 7825
[24] Stable Formulations of Peptide-Based Nanogels
Rosa, Elisabetta
Diaferia, Carlo
Gallo, Enrico
Morelli, Giancarlo
Accardo, Antonella
MOLECULES, 2020, 25 (15):
[25] Peptide-based vaccines for cancer therapy
Parmiani, Giorgio
Russo, Vincenzo
Maccalli, Cristina
Parolini, Danilo
Rizzo, Nathalie
Maio, Michele
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3175 - 3178
[26] Dendritic-cell- and peptide-based vaccination strategies for glioma
Yamanaka, Ryuya
NEUROSURGICAL REVIEW, 2009, 32 (03) : 265 - 273
[27] Linear and branched polyacrylates as a delivery platform for peptide-based vaccines
Chandrudu, Saranya
Bartlett, Stacey
Khalil, Zeinab G.
Jia, Zhongfan
Hussein, Waleed M.
Capon, Robert J.
Batzloff, Michael R.
Good, Michael F.
Monteiro, Michael J.
Skwarczynski, Mariusz
Toth, Istvan
THERAPEUTIC DELIVERY, 2016, 7 (09) : 601 - 609
[28] The present status and future prospects of peptide-based cancer vaccines
Hirayama, Masatoshi
Nishimura, Yasuharu
INTERNATIONAL IMMUNOLOGY, 2016, 28 (07) : 319 - 328
[29] The bright side of chemistry: Exploring synthetic peptide-based anticancer vaccines
D'Aniello, Antonia
Del Bene, Alessandra
Mottola, Salvatore
Mazzarella, Vincenzo
Cutolo, Roberto
Campagna, Erica
Di Maro, Salvatore
Messere, Anna
JOURNAL OF PEPTIDE SCIENCE, 2024, 30 (08)
[30] Beyond the polysaccharide and glycoconjugate vaccines for Streptococcus pneumoniae: Does protein/peptide nanovaccines hold promises?
Chandpa, Hitesh Harsukhbhai
Panda, Amulya Kumar
Meena, Chhuttan Lal
Meena, Jairam
VACCINE, 2023, 41 (50) : 7515 - 7524

← 1 2 3 4 5 →